Market Valuation: Delcath Systems Inc (DCTH)

The price action of Delcath Systems, Inc. (DCTH) securities on the GURU.Markets platform, where the metric stands at 0.70, reflects the dynamics of a liver therapy biotech. Delcath Systems, Inc. (DCTH) faces earnings uncertainty regarding Chemosat and a need for investment. The business is currently scaling sales of its unique chemoperfusion system across US clinics. Simultaneously, the company is implementing eco-friendly component recycling methods and compact packaging to comply with ESG standards.

delcath.com - DCTH Market Value (period 07/04/2022 - 11/11/2026)

Metric breakdowns and analytics for Delcath Corp (DCTH)

- current price and projected stock value:

Stock Price Delcath Systems|DCTH - Consensus Target

- company stock exchange capitalization indicators:

Market Valuation Delcath Corp|DCTH - Aggregate Business Value

- business book valuation details:

Book Value per Share Delcath Systems|DCTH - Accounting Value of Company|Market Capitalization to Book Value Ratio delcath.com|DCTH - Cumulative Company Assets

- debt obligations and liquidity statistics:

- financial results and valuation multiples details:

DCTH - Final Profit|Future Profit Delcath Systems, Inc.|DCTH - Company Value to Net Income|Forward P/E Multiple Delcath|DCTH - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Delcath Corp|DCTH - Operating profit EBITDA|Earnings per share for the last twelve months Delcath Systems|DCTH - Earnings per share for the trailing year|Quarterly EPS earnings growth delcath.com|DCTH - Earnings per share growth rate in current year|Earnings growth forecast for next year Delcath Systems, Inc.

Fundamental company valuation:Delcath Systems DCTH

Market capitalization determines the total value of Delcath Systems, Inc. (DCTH) by multiplying the current share price by the volume of issued securities. This indicator reflects market confidence in the scale of the business and its liquidity. The market capitalization dynamics of Delcath Systems, Inc. (DCTH) depend directly on the successful implementation of its sole liver perfusion system in US hospitals. Fluctuations in the curve signal the valuation's sensitivity to commercial sales of the single-product offering. The company's fundamental stability remains dependent on overcoming its product concentration risk.

Competitors of Delcath Systems, Inc. (DCTH)